Clinical Trials List
2024-10-01 - 2028-06-30
Phase III
Recruiting6
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Chi-Lu Chiang 無
- 廖映庭 無
- Yuh-Min Chen 無
- YEN-HAN TSENG 無
- Hsu-ching Huang Division of Thoracic Medicine
- Chia-I Shen 無
- 趙恒勝 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳尚俊 無
- JIN-YUAN SHIH 無
- YEN-TING LIN 無
- 黃得瑞 無
- Chia-Chi Lin 無
- 廖斌志 無
- 林宗哲 無
- 黃信端 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chien-Chung Lin 無
- 蔡政軒 無
- Chih-Chieh Yen 無
- Shang-Yin Wu 無
- Chin-Wei Kuo 無
- Seu-Chun Yang 無
- 黃怡菁 無
- Yu-Min Yeh 無
- Wu-Chou Su 無
- 黃怡璇 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林定佑 無
- Chih-Hsi Kuo 無
- 吳教恩 無
- 柯皓文 無
- 黃宗楨 無
- 枋岳甫 無
- Ping-Chih Hsu 無
- Chien-Ying Liu 無
- Chih-Liang Wang 無
- 邱立忠 無
- Chih-Hung Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林俊維 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 葉金水 Division of Thoracic Medicine
- 林慶雄 Division of Thoracic Medicine
- 陳正雄 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
- 林明泰 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
- 張時榮 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
702 participants
